Taiwan Recalls Hypothyroidism Drug Over Low Active Ingredient Levels
Taipei: Taiwan’s Food and Drug Administration (FDA) has ordered the recall of two batches of a medication used to treat hypothyroidism after stability tests found its active ingredient levels had fallen below standard, potentially reducing the drug’s effectiveness, an FDA official said Thursday. According to Focus Taiwan, the recall covers